Skip to main content
. 2018 Aug 20;9:675. doi: 10.3389/fneur.2018.00675

Figure 1.

Figure 1

The patients with anti-NMDAR encephalitis showed significant general cognitive impairments at T1 and demonstrated obvious improvements during the recovery period. MMSE, mini-mental state examination. MoCA, Montreal cognitive assessment. T1 = 1 to 2 months following initial immunotherapy. T2 = 6 months following initial immunotherapy. T3 = 11 to 12 months following initial immunotherapy. The two-sample t-test between the patients and health controls (HCs) at three time points. **p < 0.05/3 (Bonferroni correction).